Cargando…

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey

Detalles Bibliográficos
Autores principales:	Klonoff, David, Nayberg, Irina, Erbstein, Frank, Cali, Anna, Brulle-Wohlhueter, Claire, Haak, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525641/ https://www.ncbi.nlm.nih.gov/pubmed/26002837 http://dx.doi.org/10.1177/1932296815586219

Ejemplares similares

Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens
por: Klonoff, David, et al.
Publicado: (2015)

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes
por: Pohlmeier, Harald, et al.
Publicado: (2017)

Usability of devices for self-injection: results of a formative study on a new disposable pen injector
por: Lange, Jakob, et al.
Publicado: (2014)

Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
por: Klonoff, David C, et al.
Publicado: (2020)

Semaglutide single‐dose pen‐injector: Post hoc analysis of summative usability testing for weight management
por: Klonoff, David C., et al.
Publicado: (2021)

Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes
por: Ritzel, Robert, et al.
Publicado: (2017)

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
por: Ritzel, R, et al.
Publicado: (2015)

Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3
por: Bonadonna, Riccardo C., et al.
Publicado: (2018)

Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen
por: Kappes, Christopher M., et al.
Publicado: (2017)

A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen
por: Bolli, Geremia B., et al.
Publicado: (2018)

Disposal of Used Pens and Needles from Diabetes Patients Perspective
por: Catic, Tarik, et al.
Publicado: (2020)

Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)
por: Mader, Julia K, et al.
Publicado: (2022)

Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review
por: Ghosh, Sujoy, et al.
Publicado: (2023)

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
por: Danne, Thomas, et al.
Publicado: (2020)

A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study
por: Sauer, Maritta, et al.
Publicado: (2017)

Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 Requirements
por: Abdel-Tawab, Mona, et al.
Publicado: (2015)

A Comparison of Insulin Pen Devices and Disposable Plastic Syringes – Simplicity, Safety, Convenience and Cost Differences
por: Singh, Ripudaman, et al.
Publicado: (2018)

Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
por: Müller-Wieland, Dirk, et al.
Publicado: (2023)

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3
por: Yale, Jean-François, et al.
Publicado: (2018)

Feasibility and Usability of Tele-interview for Medical Residency Interview
por: Pourmand, Ali, et al.
Publicado: (2018)

Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange, Jakob, et al.
Publicado: (2018)

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy
por: Dallagiovanna, Chiara, et al.
Publicado: (2022)

SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
por: Hassanein, Mohamed, et al.
Publicado: (2020)

Evolution of Matrix Gla and Bone Gla Protein Genes in Jawed Vertebrates
por: Leurs, Nicolas, et al.
Publicado: (2021)

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis
por: Pachon, Jaime A, et al.
Publicado: (2014)

Brief Digital Solutions in Behavior Change Interventions for Type 2 Diabetes Mellitus: A Literature Review
por: Baradez, Cécile, et al.
Publicado: (2022)

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680
por: Ritzel, Robert, et al.
Publicado: (2019)

Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting—the GOAL_RO trial
por: Stegaru, Daniela, et al.
Publicado: (2021)

Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
por: Pleil, Andreas M, et al.
Publicado: (2012)

Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain
por: Ampudia‐Blasco, F. Javier, et al.
Publicado: (2023)

Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial
por: Perez, Antonio, et al.
Publicado: (2020)

Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study
por: Okajima, Fumitaka, et al.
Publicado: (2018)

Usability of a Hybrid System Combining P300-Based Brain-Computer Interface and Commercial Assistive Technologies to Enhance Communication in People With Multiple Sclerosis
por: Riccio, Angela, et al.
Publicado: (2022)

Fetuin, Matrix-Gla Protein and Osteopontin in Calcification of Renal Allografts
por: Lorenzen, Johan M., et al.
Publicado: (2012)

Acceptability to patients of screening disposable transnasal endoscopy: qualitative interview analysis
por: McGoran, John, et al.
Publicado: (2019)

Matrix Gla protein in tumoral pathology
por: GHEORGHE, SIMONA ROXANA, et al.
Publicado: (2016)

Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
por: Pleil, Andreas M, et al.
Publicado: (2014)

Impact of the Number of Needle Tip Bevels on the Exerted Forces and Energy in Insulin Pen Injections
por: Ponsiglione, Alfonso Maria, et al.
Publicado: (2023)

How Patients Dispose of Unused Prescription Opioids: A Survey of over 300 Postoperative Patients
por: Talebi, Ramin, et al.
Publicado: (2022)

An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen(®)
por: Davis, Estella M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rtm5iopif52288g9qgoto71uf7